|
Malaria is the world's most prevalent vector-borne disease causing over 2 million deaths per year, half of which are in children under 5 years of age. It is endemic in 92 countries and over 40% of the world's population is at risk.
For babies, children and adults who are weakened, ill, or system compromised, drugs are often not ingestible.
PAHEF has funded a worldwide WHO study of a new rectal suppository delivery system for artesunate medications.
The project encompasses registration, behavioral studies, packaging information, clinical trials and has controlled deployment of drugs in 6 countries.
This delivery modality, still in the study stage, could be life- saving for hundreds of thousands of persons ill with malaria.
Click below on the slides from a slide set entitled Rectal Artesunate for Community Based Emergency Treatment of Severe Malaria: Update and Next Steps from the Special Programme for Research and Training in Tropical Diseases (TDR).
- Introduction
- Overview
- Field Realities
- Knowledge of Drug
- Requirements
- Proposals
|
